Steve Eppler
发表论文 24 篇 · 总被引 1175 次 · h-index 11
代表论文
- Clinical pharmacokinetics of bevacizumab in patients with solid tumors (2008 · Cancer Chemotherapy and Pharmacology · 被引 349)
- Clinical pharmacokinetics of erlotinib in patients with solid tumors and exposure-safety relationship in patients with non–small cell lung cancer (2006 · Clinical Pharmacology & Therapeutics · 被引 225)
- Pharmacokinetics of Ranibizumab in Patients with Neovascular Age-Related Macular Degeneration: A Population Approach (2013 · Investigative Ophthalmology & Visual Science · 被引 200)
- Evaluation of the Absolute Oral Bioavailability and Bioequivalence of Erlotinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in a Randomized, Crossover Study in Healthy Subjects (2006 · The Journal of Clinical Pharmacology · 被引 112)
- Phase I Dose-Escalation Study of Onartuzumab as a Single Agent and in Combination with Bevacizumab in Patients with Advanced Solid Malignancies (2014 · Clinical Cancer Research · 被引 66)
- Developmental Immunotoxicology Assessment of Rituximab in Cynomolgus Monkeys (2010 · Toxicological Sciences · 被引 64)